CHI3L1 and Cognitive impairment: They divided the participants into cognitively normal, stable mild cognitive impairment, progressive MCI, and Alzheimer’s dementia and they found that YKL-40 levels can be a predictor of AD diagnosis and are associated with hippocampal atrophy.